CASU, Gavino
 Distribuzione geografica
Continente #
NA - Nord America 5.385
AS - Asia 4.287
SA - Sud America 2.572
EU - Europa 1.638
Continente sconosciuto - Info sul continente non disponibili 242
AF - Africa 155
OC - Oceania 5
Totale 14.284
Nazione #
US - Stati Uniti d'America 5.175
BR - Brasile 2.278
SG - Singapore 2.148
CN - Cina 717
IT - Italia 630
VN - Vietnam 396
HK - Hong Kong 382
DE - Germania 228
FR - Francia 200
AR - Argentina 102
BD - Bangladesh 101
CA - Canada 88
UA - Ucraina 85
GB - Regno Unito 80
IN - India 80
FI - Finlandia 77
RU - Federazione Russa 71
TR - Turchia 71
IQ - Iraq 64
MX - Messico 64
EC - Ecuador 54
NL - Olanda 51
UZ - Uzbekistan 47
ZA - Sudafrica 47
JP - Giappone 38
AT - Austria 37
SE - Svezia 37
VE - Venezuela 37
CO - Colombia 32
PK - Pakistan 30
KR - Corea 27
PL - Polonia 26
MA - Marocco 25
ID - Indonesia 23
KE - Kenya 22
ES - Italia 21
CZ - Repubblica Ceca 19
PE - Perù 19
JO - Giordania 18
PY - Paraguay 18
NP - Nepal 16
CL - Cile 15
KZ - Kazakistan 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
JM - Giamaica 10
SA - Arabia Saudita 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
LB - Libano 9
BE - Belgio 8
PH - Filippine 8
AL - Albania 7
CR - Costa Rica 7
IL - Israele 7
KG - Kirghizistan 7
MY - Malesia 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 7
BO - Bolivia 5
CH - Svizzera 5
ET - Etiopia 5
GR - Grecia 5
GT - Guatemala 5
HU - Ungheria 5
NI - Nicaragua 5
SN - Senegal 5
AU - Australia 4
BG - Bulgaria 4
HN - Honduras 4
RO - Romania 4
RS - Serbia 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
GE - Georgia 3
IR - Iran 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
OM - Oman 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
IE - Irlanda 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
Totale 14.027
Città #
Dallas 1.974
Singapore 1.145
San Jose 724
Hong Kong 374
Ashburn 313
Santa Clara 304
Council Bluffs 282
Beijing 253
Columbus 216
São Paulo 171
Lauterbourg 148
Ho Chi Minh City 136
Shanghai 119
Hanoi 96
Los Angeles 81
Munich 72
Chandler 67
New York 67
Belo Horizonte 66
Rio de Janeiro 66
Helsinki 46
Rome 46
Orem 45
Milan 43
Brasília 42
Curitiba 42
Nuremberg 42
Tashkent 41
Phoenix 39
Frankfurt am Main 38
Jacksonville 34
Tokyo 34
Porto Alegre 33
Boardman 28
Sassari 28
Brooklyn 27
Johannesburg 27
Campinas 26
Chennai 26
Romola 26
Tianjin 26
Baghdad 25
Cagliari 24
Da Nang 24
Montreal 24
Seoul 24
Boston 23
Amsterdam 22
Princeton 22
Ribeirão Preto 22
Warsaw 21
Ann Arbor 20
Atlanta 20
Düsseldorf 20
Guayaquil 20
Nairobi 20
Salvador 20
Toronto 20
Wilmington 20
Denver 19
Vienna 19
Guarulhos 18
Istanbul 18
Falkenstein 17
Quito 17
Amman 16
Dhaka 16
Florence 16
Houston 16
London 16
Santo André 16
Sorocaba 16
Stockholm 16
Uberlândia 16
Belford Roxo 15
Chicago 15
Lima 15
Baku 14
Buenos Aires 14
Mexico City 14
Seattle 14
Betim 13
Caracas 13
Dearborn 13
Juiz de Fora 13
Nanjing 13
San Francisco 13
Ankara 12
Brno 12
Gravataí 12
Manchester 12
Mauá 12
São José dos Campos 12
Turku 12
Aracaju 11
Bogotá 11
Canoas 11
Fortaleza 11
Goiânia 11
João Pessoa 11
Totale 8.385
Nome #
Left atrial appendage occlusion: behind the bleeding risk 227
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 180
Left Atrial Appendage Closure vs. Oral Anticoagulation: still a matter of debate 176
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 162
Brain anticipatory cardiovascular responses to exercise 161
Permanent pacemaker dependency after transcatheter aortic valve implantation: Prevalence, patients’ characteristics, and main determinants 155
Aging of the Arterial System 146
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 141
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 136
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 136
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 135
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 135
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 134
Diagnosis of Brugada syndrome affects quality of life and psychological status 134
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 126
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 119
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 118
Integrating Pharmacological Features to Personalized Models With Statin Therapy 118
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 115
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 114
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 113
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 113
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 109
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 108
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: A webthal study 108
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 106
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 106
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 105
Serum albumin and mortality risk in old patients with acute ischemic stroke. 104
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 103
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 103
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 102
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 101
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 101
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 101
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 100
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 100
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 99
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 99
Effect of rhTSH on Lipids 99
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 98
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 97
Abstract 110: Quality of life in Beta Thalassemia 97
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 96
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 96
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 95
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 95
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension 95
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 94
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 94
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 93
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 93
Letter to the editor 92
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 91
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 90
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 89
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 89
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 89
Anomalous origin of right coronary artery from left sinus of valsalva 88
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 88
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 88
The experience of immersive virtual reality in patients with heart failure during cardiac rehabilitation: a qualitative study 88
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 87
Correspondence 87
Prevalence of the RR genotypes of the locus ACTN3-R577X in Italian Muay Thai elite fighters 86
Virtual reality and cardiac rehabilitation: a new middle-range theory to outline its mechanism of effectiveness 86
Vascular assisted-tracking for challenging transradial percutaneous intervention 86
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics 85
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 85
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 85
Highly specialized stroke care improves the 30-day survival 85
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 84
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 84
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 83
Does the age affect the outcomes of cardiac resynchronization therapy in elderly patients? 83
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment 82
Subsequent Event Risk in Individuals With Established Coronary Heart Disease 82
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 81
Impact of Selection Bias on Estimation of Subsequent Event Risk 81
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 81
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 80
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 79
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 78
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 78
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 77
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 77
Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: Insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry 77
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 77
Novel Perspectives on Genetic Evaluation in Early-Onset Atrial Fibrillation: Clinical Implications and Future Directions 76
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 75
The strategic alliance between clinical and molecular science in the war against sars-cov-2, with the rapid-diagnostics test as an indispensable weapon for front line doctors 75
Effectiveness of virtual reality on pain and anxiety in patients undergoing cardiac procedures: A systematic review and meta-analysis of randomized controlled trials 75
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 74
Diuretic therapy in heart failure - Current approaches 73
The Italian registry of renal denervation 73
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 73
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension 73
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 73
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry 73
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry 72
Totale 10.004
Categoria #
all - tutte 59.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20254.896 16 91 292 132 172 200 258 856 1.786 730 211 152
2025/20267.399 322 1.662 752 1.077 808 361 1.044 193 355 479 242 104
2026/20271.057 177 636 244 0 0 0 0 0 0 0 0 0
Totale 14.284